Microbiology News: clinical, Sep 2021
Special rapidmicrobiology Focus on COVID-19 Immunity Testing
27 Sep 2021 | ClinicalPharmaceutical
Free Hardy Diagnostics Webinar to Cover Detection of Carbapenemase Producing Organisms
24 Sep 2021 | Clinical
Evaluating Immune Response to COVID-19 using CE-IVD Neutralizing Antibody ELISA Kit
22 Sep 2021 | ClinicalPharmaceutical
Rapid Antibody Test Manufacturer Wins Gold and Bronze at Recent Healthcare Award Ceremony
22 Sep 2021 | Clinical
SARS-CoV-2 Neutralizing Antibody Test is FDA-EUA and CE-Marked
22 Sep 2021 | Clinical
Rapid IgM/IgG Antibody Test Vital for COVID-19 Vaccination Program
20 Sep 2021 | Clinical
Bacterial and Viral Biomarker Test Gains US FDA Clearance
20 Sep 2021 | Clinical
200+ Recombinant SARS-CoV-2 Variants Bank for Vaccine Research
09 Sep 2021 | Clinical
MALDI-Link™ Middleware with BIOMIC V3
08 Sep 2021 | Clinical
Highly-Specific Neutralizing Antibodies for COVID-19 Vaccine Potency and Immunity Studies
07 Sep 2021 | Clinical
Introducing HardyCHROM™ Group A Strep Agar with Easy to Read Color Differentiation
06 Sep 2021 | Clinical
Cloud-Based Platform Bridges Gap Between Patients and Clinical Testing Labs
06 Sep 2021 | Clinical
Evaluate Vaccination with Recombinant SARS-CoV-2 Antigens with Critical Mutations
06 Sep 2021 | Clinical
New SARS-CoV-2 Whole Virus Antigen Controls for Point-of-Care COVID-19 Diagnostics
01 Sep 2021 | Clinical